Medinox,Inc.
Records under this name other than patents Medinox,Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE41,151 | Protected forms of pharmacologically active agents and uses thereof Term ended Term ended Jun 23, 2020 · From the USPTO record | Term ended | Term ended Jun 23, 2020 | From the USPTO record |
| US 6,295,736 | Blade ejection mechanism for a saw blade clamping arrangement of a power tool Formerly held Term ended Term ended Oct 12, 2019 · From the USPTO record | Term ended | Term ended Oct 12, 2019 | From the USPTO record |
| US 6,124,349 | Method for preparation of pharmaceutical-grade dithiocarbamate Term ended Term ended Feb 18, 2019 · From the USPTO record | Term ended | Term ended Feb 18, 2019 | From the USPTO record |
| US 6,429,223 | Modified forms of pharmacologically active agents and uses therefor Lapsed on the fee record Ended Aug 6, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2014 | From the USPTO record |
| US 6,355,661 | Methods for treatment of sickle cell anemia Lapsed on the fee record Ended Mar 12, 2010 · From the USPTO record | Lapsed on the fee record | Ended Mar 12, 2010 | From the USPTO record |
| US 6,355,666 | Protected forms of pharmacologically active agents and uses therefor Surrendered on reissue Surrendered on reissue Feb 23, 2010 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Feb 23, 2010 | From the USPTO record |
| US 6,251,927 | Methods for treatment of sickle cell anemia Lapsed on the fee record Ended Jun 26, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2009 | From the USPTO record |
| US 6,710,086 | Protected forms of pharmacologically active agents and uses therefor Lapsed on the fee record Ended Mar 23, 2008 · From the USPTO record | Lapsed on the fee record | Ended Mar 23, 2008 | From the USPTO record |
| US 6,649,591 | Polydithicarbamate-containing non-targeting marcomolecules and the use thereof for therapeutic and diagnostic applications Lapsed on the fee record Ended Nov 18, 2007 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2007 | From the USPTO record |
| US 6,620,813 | Hydroxamate derivatives of non-steroidal anti-inflammatory drugs Lapsed on the fee record Ended Sep 16, 2007 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2007 | From the USPTO record |